Your Article Summary
Febrile reactions occurring with second cycle of high-dose melphalan and SCT in patients with AL amyloidosis
Bone Marrow Transplantation, 05/08/09
Rosenzweig M et al. - The authors conclude that an unusual cytokine-mediated febrile reaction can occur in patients with AL amyloidosis exposed to a second cycle of high-dose melphalan, which they have termed a 'melphalan recall' reaction.
Related Articles
Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial
Haematologica, 10/07/09
Relevance Score: 88%
Parental stress and perceived vulnerability at 5 and 10 years after pediatric SCT
Bone Marrow Transplantation, 11/05/09
Relevance Score: 87%
Management of relapse after allo-SCT for AML and the role of second transplantation
Bone Marrow Transplantation, 10/29/09
Relevance Score: 87%
Economic evaluation of posaconazole vs fluconazole in the prevention of invasive fungal infections in patients with GVHD following haematopoietic SCT
Bone Marrow Transplantation, 10/07/09
Relevance Score: 87%
Matched unrelated donor stem cell transplant in 131 patients with follicular lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
British Journal of Haematology, 10/06/09
Relevance Score: 87%
Today in Amyloidosis...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical features and functional significance of the P369S/ R408Q variant in pyrin, the familial Mediterranean fever protein
Annals of Rheumatic Diseases, 12/11/09
MEFV mutations in Egyptian patients suffering from familial Mediterranean fever: analysis of 12 gene mutations
Rheumatology International, 10/16/09
Classification of amyloidosis by laser microdissection and mass spectrometry based proteomic analysis in clinical biopsy specimens
Blood, 10/09/09

See Latest Articles